Questionable Health Behaviors and Their Distal and Proximal Correlates (REASON4HEALTH)

November 28, 2023 updated by: Ljiljana Lazarevic, University of Belgrade

Questionable Health Behaviors and Their Distal and Proximal Correlates: Protocol for a Nationally Representative Survey in Serbia

The goals of the study:

  1. to investigate the frequency of Traditional, Complementary and Alternative Medicine use (TCAM) and intentional Non-adherence to medical recommendations (iNAR) in the general population in Serbia, as well as their mutual relations.
  2. to examine the distribution of irrational beliefs in the general population;
  3. to explore the relationships between TCAM and iNAR behaviors on the one hand and variables of personality, thinking styles and cognitive reflection on the other, with a major assumption that these relationships will be mediated by the domain of irrational beliefs and socio-political attitudes.

Participants will respond to a battery of instruments assessing TCAM use and iNAR, as well as, sociodemographics and health-related variables (such as health status, chronic diseases, BMI, etc.), distal psychological (i.e. personality, thinking disposition and styles) and proximal psychological, variables, (i.e. the irrational mindset, as well as socio-political beliefs and attitudes).

Data will be collected on the probabilistic household sample representative for the general population in Serbia (N=1043).

Study Overview

Study Type

Observational

Enrollment (Actual)

1043

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belgrade, Serbia, 11000
        • Faculty of Philosophy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

general population

Description

Inclusion Criteria:

  • must be at least 18 years of age

Exclusion Criteria:

  • the inability to understand the Serbian language
  • failure to pass any of the four attention-check questions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
General population

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Traditional, complementary and alternative medicine (TCAM) use
Time Frame: baseline
Prevalence of TCAM use
baseline
intentional non-adherence to official medical recommendations (iNAR)
Time Frame: baseline
Prevalence of iNAR
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Goran Knezevic, prof., Department of Psychology, Faculty of Philosophy, University of Belgrade

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2023

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

March 28, 2023

First Submitted That Met QC Criteria

April 10, 2023

First Posted (Actual)

April 11, 2023

Study Record Updates

Last Update Posted (Estimated)

December 4, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 7739597 (Other Grant/Funding Number: Science Fund of the Republic of Serbia)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe